Affinity Asset Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $12.3M | Sell |
|
|||||
|
2023
Q1 | $22.6M | Buy |
|
|||||
|
2022
Q4 | $21.4M | Buy |
|
|||||
|
2022
Q3 | $16M | Sell |
|
|||||
|
2022
Q2 | $16.4M | Buy |
|
|||||
|
2022
Q1 | $13.8M | Buy |
|
|||||
|
2021
Q4 | $9.05M | Buy |
|
|||||
|
2021
Q3 | $949K | Sell |
|
|||||
|
2021
Q2 | $2.82M | Buy |
|
|||||
|
2021
Q1 | $2.72M | Buy |
|
|||||
|
2020
Q4 | $2.38M | Buy |
|